Skip to main content
Enterprise AI Analysis: Single-cell and spatial transcriptomic profiling of cardiac fibroblasts following myocardial infarction

Enterprise AI Analysis

Single-cell and spatial transcriptomic profiling of cardiac fibroblasts following myocardial infarction

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Executive Impact at a Glance

Leverage the power of cutting-edge multi-omics research to drive innovation in cardiovascular health and regenerative medicine.

27995 Cardiac Fibroblasts Profiled
3 Datasets Integrated
5 Days Post-Infarction Studied
17 Cell Clusters Identified

Deep Analysis & Enterprise Applications

Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.

Peak Activation Period for RCF Marker Genes

3-5 dpi

Bulk RNA-seq analysis revealed that highly relevant Reparative Cardiac Fibroblast (RCF) marker genes, including Cthrc1, Ddah1, Postn, Fn1, Lox, and Ptn, exhibited peak expression between 3 and 5 days post-infarction (dpi). This defines a critical window for RCF activation.

RCF Activation & Differentiation Pathway

Myocardial Infarction (MI)
Activation of Periostin (Postn)+ CFs
Transition to Cthrc1+ Reparative CFs (RCFs)
Scar Formation & Ventricular Repair

Multi-modal Data Integration for CF Heterogeneity

MethodologyContribution to Understanding CFs
Bulk RNA Sequencing
  • Defined optimal time points for RCF activation (3-5 dpi), validated marker gene expression dynamics.
Single-cell RNA Sequencing
  • Characterized CF subpopulations (17 clusters), identified transitional states and RCF origin from Postn+ CFs.
Spatial Transcriptomics
  • Mapped anatomical and temporal gene expression changes, revealed RCF enrichment in infarct zone (IZ) and a gradient from RZ to IZ.

Asporin (Aspn) as a Key Regulator

D2 Dynamics

Asporin (Aspn) was identified as a critical gene within the D2 transcriptional dynamics, associated with TGF-β signaling and ECM molecules. Aspn loss-of-function leads to a Cthrc1-KO-like phenotype of ventricular rupture, highlighting its importance in cardiac remodeling.

Translational Validation Across Species

The identified D2-associated gene expression patterns, including Asporin up-regulation, were consistently detected across mouse, pig, and human cardiac datasets. This cross-species and multi-platform validation underscores the translational relevance of the findings for cardiac research.

Impact: This robust validation across different animal models and human samples significantly enhances the applicability of the dataset for developing novel therapeutic strategies targeting cardiac fibrosis in humans, accelerating the transition from bench to bedside.

Dataset Availability

Publicly Available

All data, including single-cell RNA-seq (GSE261428), bulk RNA-seq (GSE267256), and spatial transcriptomics (GSE265828), are publicly available on NCBI's Gene Expression Omnibus, along with code on GitHub, ensuring broad reusability for the scientific community.

Calculate Your Potential AI-Driven ROI

Estimate the efficiency gains and cost savings your organization could achieve by integrating advanced AI solutions based on this research.

Annual Cost Savings
Annual Hours Reclaimed

Your AI Implementation Roadmap

A phased approach to integrate these insights into your enterprise, ensuring maximum impact and smooth transition.

Phase 1: Discovery & Strategy

Duration: 2-4 Weeks

Conduct a comprehensive audit of existing systems and workflows. Identify key integration points and define success metrics. Develop a tailored AI strategy aligning with organizational goals.

Phase 2: Data Engineering & Model Development

Duration: 6-12 Weeks

Prepare and cleanse relevant datasets. Develop and train custom AI models based on the identified research insights. Ensure data privacy and security compliance.

Phase 3: Integration & Pilot Deployment

Duration: 4-8 Weeks

Seamlessly integrate AI models into your current infrastructure. Conduct pilot programs in a controlled environment to test performance and gather user feedback.

Phase 4: Scaling & Optimization

Duration: Ongoing

Full-scale deployment across relevant departments. Continuous monitoring, evaluation, and fine-tuning of AI models for sustained performance and evolving needs.

Ready to Transform Your Enterprise?

Schedule a free, no-obligation consultation with our AI strategists to explore how these advanced insights can be customized for your organization's unique challenges and opportunities.

Ready to Get Started?

Book Your Free Consultation.

Let's Discuss Your AI Strategy!

Lets Discuss Your Needs


AI Consultation Booking